Next 10 |
home / stock / mrv:cc / mrv:cc news
Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare (TSX:MRV; OTCQX:MRVFF) (“ Miravo ” or the “ Company ”) is pleased to announce that it has obtained a final court order from the Ontario Superior Court of Justice (Commercial List) approving its previously announ...
Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare (TSX:MRV; OTCQX:MRVFF) (“ Miravo ” or the “ Company ”) is pleased to announce that, at today’s special meeting of shareholders (the “ Meeting ”), its shareholders (“ Shareho...
Shareholders are reminded to vote their common shares prior to the proxy voting deadline of 9:00 a.m. (Toronto Time) on March 3, 2023 Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare (TSX:MRV; OTCQX:MRVFF) (“ Miravo ” or the “ Company ”) reminds it...
Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare (TSX:MRV; OTCQX:MRVFF) (“ Miravo ” or the “ Company ”) announced today that it has filed and is in the process of mailing the management information circular (the “ Circular ”) and related mate...
Miravo shareholders to receive $ 1.35 per common share in cash, reflecting a premium of 79.8% to the 90-day volume weighted average price per common share on the Toronto Stock Exchange for the period ended December 22, 2022 Agreement entered into after a thorough review of all alt...
- Blexten Canadian Prescriptions Increased 27% Quarter-Over-Prior Year Quarter- - Suvexx Canadian Prescriptions Increased 86% Quarter-Over- Prior Year Quarter – Miravo to Host Conference Call/Audio Webcast November 14th at 11:00 a.m. ET ...
Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company) , a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products, today announced it expects to release its third quarter 2022 financial resu...
Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, today announced the appointment of Anthony Snow to its Board of Directors (Board)...
- Blexten Canadian Prescriptions Increased 17% Year-Over-Year - - Suvexx Canadian Prescriptions Increased 85% Year-Over-Year - - Plans to Wind-Down Manufacturing Facility in Varennes, Québec - Miravo to Host Conference Call/Audio Webcast Augu...
Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products, today announced it expects to release its second quarter 2022 financial results ...
News, Short Squeeze, Breakout and More Instantly...
Nuvo Pharmaceuticals Inc. Company Name:
MRV:CC Stock Symbol:
TSXC Market:
Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare (TSX:MRV; OTCQX:MRVFF) (“ Miravo ” or the “ Company ”) is pleased to announce that it has obtained a final court order from the Ontario Superior Court of Justice (Commercial List) approving its previously announ...
Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare (TSX:MRV; OTCQX:MRVFF) (“ Miravo ” or the “ Company ”) is pleased to announce that, at today’s special meeting of shareholders (the “ Meeting ”), its shareholders (“ Shareho...
Shareholders are reminded to vote their common shares prior to the proxy voting deadline of 9:00 a.m. (Toronto Time) on March 3, 2023 Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare (TSX:MRV; OTCQX:MRVFF) (“ Miravo ” or the “ Company ”) reminds it...